Continuing Education

The 2024 Annual Meeting Main Program, Opening Symposium, and Menopause 101 and Cognitive-Behavioral Therapy 101 courses offer opportunities to earn continuing education credits or certificates of participation by attending the events in person or by participating in the OnDemand virtual offering. For nurses and other learners who need to report contact hours of pharmacotherapeutic education, there also will be the option to earn pharmacotherapeutic credits.

Learning Objectives

Menopause 101 Course 

By participating in this activity, attendees should be able to 

• Review menopause definitions, terminology, and adrenal physiology and discuss symptoms prevalent during each stage of menopause.
• Describe the basic physiology of vasomotor symptoms (VMS), racial and ethnic differences in symptomatology, and the hormone and nonhormone treatment options.
• Understand hormone therapy (HT) indications and contraindications, the types of HT available, and the timing hypothesis.
• Define female sexual dysfunction as it pertains to perimenopause and menopause, the available treatment options, and the indications for sex and pelvic therapy. 
• Understand the basic physiology of genitourinary syndrome of menopause (GSM) and the hormone and nonhormone treatment options. 
• Review mood, sleep, and cognitive changes during the menopause transition and management approaches for each. 
• Outline the relationship between menopause and weight gain and the exercise and dietary recommendations. 
• Explore the risk factors for cardiovascular disease and osteoporosis. 

Cognitive-Behavioral Therapy 101 Course 

By participating in this activity, attendees should be able to 

• Review the foundations of cognitive-behavioral therapy (CBT).
• Outline the options for CBT in the treatment of menopause symptoms. 
• Describe the role of CBT for sleep problems at midlife. 
• Discuss how CBT can be used in treating sexual dysfunction at midlife. 
• Understand how CBT can be incorporated into a clinical setting. 

Annual Meeting Main Program and Opening Symposium 

By participating in this activity, attendees should be able to 

• Assess the role and ethics of artificial intelligence (AI) in midlife women’s health. 
• Recognize and manage irregular bleeding during the menopause transition and review the near-term and future options for menopause management. 
• Understand what causes depression during menopause and review cognition and hormone therapy use. 
• Explore hair loss, immunization options, and bone health at midlife. 
• Discuss healthy weight at midlife, the role of nutrition, and the recent treatment options for obesity. 
• Appreciate the issues surrounding menopause and the workplace and review the options to assist employers and employees. 
• Evaluate sexual health issues at midlife, including genitourinary syndrome of menopause and hypoactive sexual desire disorder. 
• Become familiar with managing substance use during midlife. 
• Discuss sleep disturbances in women with breast cancer and pharmacologic and behavioral approaches to treating menopause-associated insomnia. 

Consider the latest information on managing menopause and whether too much or not enough is being done. 

Continuing Medical Education Credits and Pharmacotherapeutic Hours—In-Person Meeting

Menopause 101 Course—September 10, 2024—1:00 PM–5:15 PM 

The Menopause Society designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Other healthcare professionals who participate in this activity will receive a certificate of participation. A maximum of 2.0 pharmacotherapeutic hours are available. 

Cognitive-Behavioral Therapy 101 Course—September 10, 2024—1:00 PM–5:00 PM 

The Menopause Society designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Other healthcare professionals who participate in this activity will receive a certificate of participation. 

Opening Symposium—Artificial Intelligence and Midlife Women’s Health: Are We There Yet? and Main Program—Humanizing Artificial Intelligence to Improve Midlife Women’s Health—September 11-14, 2024 

The Menopause Society designates this live activity for a maximum of 26.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Other healthcare professionals who participate in this activity will receive a certificate of participation. A maximum of 8.5 pharmacotherapeutic hours are available. 

Continuing Medical Education Credits and Pharmacotherapeutic Hours—On-Demand Virtual Offerings

Menopause 101 Course 

The Menopause Society designates this internet enduring activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Other healthcare professionals who participate in this activity will receive a certificate of participation. A maximum of 2.0 pharmacotherapeutic hours are available. 

Cognitive-Behavioral Therapy 101 Course 

The Menopause Society designates this internet enduring activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Other healthcare professionals who participate in this activity will receive a certificate of participation. 

Opening Symposium—Artificial Intelligence and Midlife Women’s Health: Are We There Yet? and Main Program—Humanizing Artificial Intelligence to Improve Midlife Women’s Health—September 11-14, 2024

The Menopause Society designates this internet enduring activity for a maximum of 22.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Other healthcare professionals who participate in this activity will receive a certificate of participation. A maximum of 8.0 pharmacotherapeutic hours are available.